Common use of Immediate Termination of Trial by Sponsor Clause in Contracts

Immediate Termination of Trial by Sponsor. Sponsor further reserves the right to terminate the Trial immediately upon written notification to Provider for causes that include failure to enroll Trial Subjects at a rate sufficient to achieve Trial performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in Sponsor’s opinion pose risks to the health or wellbeing of Trial Subjects; or regulatory agency actions relating to the Trial or the Sponsor Drug or Comparator Drug. (3)

Immediate Termination of Trial by Sponsor. Sponsor further reserves the right to terminate the Trial immediately upon written notification to Provider Institution for causes that include failure to enroll Trial Subjects at a rate sufficient to achieve Trial performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in Sponsor’s opinion pose risks to the health or wellbeing of Trial Subjects; or regulatory agency actions relating to the Trial or the Sponsor Drug or Comparator Drug. (3)

Immediate Termination of Trial by Sponsor. Sponsor further reserves the right to terminate the Trial immediately upon written notification to Provider Institution for causes that include failure to enroll Trial Subjects at a rate sufficient to achieve Trial performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in Sponsor’s opinion pose risks to the health or wellbeing well being of Trial Subjects; or regulatory agency actions relating to the Trial or the Sponsor Drug or Comparator Drug. (32)

Immediate Termination of Trial by Sponsor. Sponsor further reserves the right to terminate the Trial immediately upon written notification to Provider Institution for causes that include failure to enroll Trial Subjects at a rate sufficient to achieve Trial performance goals; material unauthorized deviations from the Protocol or reporting requirements; circumstances that in Sponsor’s opinion pose risks to the health or wellbeing of Trial Subjects; or regulatory agency RA actions relating to the Trial or the Sponsor Drug or Comparator Drug. (3)

Immediate Termination of Trial by Sponsor. Sponsor further reserves the right to terminate the Trial immediately upon written notification to Provider Institution and Investigator for causes that include failure to enroll Trial Subjects at a rate sufficient to achieve Trial performance goals; cause, which includes material unauthorized deviations from the Protocol or reporting requirements; circumstances that in Sponsor’s opinion pose risks to the health or wellbeing well-being of Trial Subjects; or regulatory agency Regulatory Authority actions relating to the Trial or the Sponsor Drug or Comparator Drug. (3)Additional Drugs or placebo.